DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
AI in Clinical Development: A Global Primer on Regulatory Expectations Webinar
Whether your organization is exploring early use cases or scaling AI-driven capabilities, this session will deliver strategic insights and practical guidance. Attendees will gain a foundational understanding of how to navigate AI adoption with confidence, enabling informed decision making and alignment with regulatory expectations.
As Artificial Intelligence (AI) becomes increasingly embedded in clinical development and regulatory processes, global health authorities have responded with a range of evolving guidelines to ensure safety, transparency, data privacy, and compliance. From optimizing trial design and accelerating patient recruitment to generating insights in regulatory submissions, AI holds transformative potential but also introduces novel regulatory challenges.
In this session, we’ll provide:
- Practical overview of the current landscape of international AI regulatory guidance
- Latest positions and frameworks from key agencies, highlighting prioritized principles
- Categories of AI addressed
- Nuances across global jurisdictions of AI addressed
RELATED ARTICLES
Carolina Ahrendt, MBA, PMPMay 22, 2025 9:45:53 AM1 min read
Mastering Program Management and Leadership: Five Pillars to Drug Development Excellence Webinar
Join our webinar to clarify the roles of Program Leaders (PL) and Program Managers (PM) in drug development. Learn how they ...
Start Reading
Meghan Patterson, MPHMay 2, 2025 11:23:42 AM3 min read
Balancing Simplicity and Complexity in Clinical Trial Design
Designing clinical trials is a nuanced process that often pits the ideal of simplicity against the reality of scientific, ...
Start Reading
Meghan Patterson, MPHApr 22, 2025 12:32:06 PM4 min read
ICH E6(R3) and a Risk-Based Approach as a Competitive Advantage
By Meghan Patterson
Start Reading